Nuvalent (NUVL) CDO nets 5,500-share sale after option exercise
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Nuvalent, Inc. Chief Development Officer Darlene Noci reported an exercise-and-sell transaction in Class A Common Stock. On April 29, 2026, she exercised 5,500 stock options at $27.85 per share and sold 5,500 shares in multiple open‑market trades around the $99–$101 range. After these transactions, she directly held 63,617 shares of Class A Common Stock. The filing notes the trades were made under a pre‑arranged Rule 10b5‑1 trading plan adopted on November 18, 2024, indicating the timing was set in advance.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 5,500 shares ($547,524)
Net Sell
5 txns
Insider
Noci Darlene
Role
Chief Development Officer
Sold
5,500 shs ($548K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 5,500 | $0.00 | -- |
| Exercise | Class A Common Stock | 5,500 | $27.85 | $153K |
| Sale | Class A Common Stock | 4,500 | $99.35 | $447K |
| Sale | Class A Common Stock | 700 | $100.14 | $70K |
| Sale | Class A Common Stock | 300 | $101.17 | $30K |
Holdings After Transaction:
Stock Option (Right to Buy) — 92,329 shares (Direct, null);
Class A Common Stock — 63,617 shares (Direct, null)
Footnotes (1)
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.89 to $99.83, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.89 to $100.51, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.09 to $101.30, inclusive. The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Key Figures
Shares sold: 5,500 shares
Sale prices: $99.35, $100.14, $101.17 per share
Options exercised: 5,500 shares at $27.85
+3 more
6 metrics
Shares sold
5,500 shares
Class A Common Stock sold in open market on April 29, 2026
Sale prices
$99.35, $100.14, $101.17 per share
Weighted average prices across three sale tranches
Options exercised
5,500 shares at $27.85
Stock Option (Right to Buy) exercise on April 29, 2026
Shares held after
63,617 shares
Direct Class A Common Stock ownership following transactions
Trading plan adoption date
November 18, 2024
Rule 10b5-1 trading plan governing the reported trades
Remaining options
92,329 options
Total stock options following derivative transaction entry
Key Terms
Rule 10b5-1 trading plan, weighted average price, Stock Option (Right to Buy), Class A Common Stock, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" with underlying Class A Common Stock"
Class A Common Stock financial
"security_title: "Class A Common Stock" for the non-derivative transactions"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion" for the option exercise code M"
FAQ
What insider transaction did Nuvalent (NUVL) report for Darlene Noci?
Nuvalent’s Chief Development Officer Darlene Noci exercised 5,500 stock options and sold 5,500 shares of Class A Common Stock in open‑market transactions, all on April 29, 2026, according to a Form 4 insider trading report.
What stock options did Darlene Noci exercise in the Nuvalent (NUVL) filing?
She exercised 5,500 stock options with a conversion or exercise price of $27.85 per share, converting them into an equal number of Nuvalent Class A Common shares before executing same‑day open‑market sales of those shares.
What role does Darlene Noci hold at Nuvalent (NUVL) in this Form 4?
In the Form 4 filing, Darlene Noci is identified as an officer of Nuvalent, serving as Chief Development Officer, and the reported transactions involve her direct ownership of Class A Common Stock and related stock options.